Search Results
ASCO 2009: PARP inhibitors show promise for hard-to-treat breast cancers
ASCO 2009: PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer
New Drug Holds Promise In Some Cancers
PARP Inhibitors for Cancer Treatment - Part4
Dr. Donna McNamara on PARP Inhibitors for Ovarian Cancer Treatment
Dr. Markman Discusses the Olaparib Phase II Trial
PARP Inhibitors: a Breakthrough in Cancer Therapy?
Report from ASCO Focusing on Metastatic Breast Cancer
How Breast Cancer Now helped discover PARP inhibitors
PARP Inhibitors for Cancer Treatment - Part3
ASCO 2009: Maintenance therapy for NSCLC
Doctors Test Cancer 'Wonder Drug'
